למטרדה
sanofi israel ltd - alemtuzumab - תרכיז להכנת תמיסה לאינפוזיה - alemtuzumab 12 mg / 1.2 ml - alemtuzumab
דאלאצין % 2 קרם וגינלי
pfizer pfe pharmaceuticals israel ltd - clindamycin phosphate - קרם - clindamycin phosphate 2 %w/w - clindamycin - clindamycin - treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.
זינט תרחיף 125 מג5 מל
novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 25 mg/ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible microorganisms.
זינט תרחיף 250 מג5 מל
novartis israel ltd., israel - cefuroxime as axetil - suspension - cefuroxime as axetil 50 mg/ml ml - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organism.
צפואבניר 250 מג
bioavenir ltd, israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 250 mg - cefuroxime
צפואבניר 500 מג
bioavenir ltd, israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 500 mg - cefuroxime
קסמיאול
dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ג'ל - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - betamethasone - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.
בנזמיצין טופיקל ג'ל
perrigo israel agencies ltd - benzoyl peroxide; erythromycin - ג'ל - benzoyl peroxide 87.125 mg/g; erythromycin 0.8 g - benzoyl peroxide, combinations - benzoyl peroxide, combinations - for topical treatment of acne vulgaris.
דאלאצין פתילות ואגינליות
pfizer pfe pharmaceuticals israel ltd - clindamycin as phosphate - פתילות - clindamycin as phosphate 100 mg - clindamycin - clindamycin - dalacin vaginal ovules are indicated for 3-day treatment of bacterial vaginosis in non-pregnant women.
איקסל 25 מג
perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.